Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CEMIPLIMAB vs CEPHALEXIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CEMIPLIMAB vs CEPHALEXIN: Safety Overview

Metric CEMIPLIMAB CEPHALEXIN
Total FAERS Reports 1,020 7,901
Deaths Reported 175 295
Death Rate 17.2% 3.7%
Hospitalizations 651 1,832
Average Patient Age 68.9 yrs 54.7 yrs
% Female Patients 36.6% 73.4%
FDA Approval Date N/A Approved Prior to Jan 1, 1982
Manufacturer Regeneron Pharmaceuticals, Inc. AMELLA PHARMA, LLC
Route INTRAVENOUS ORAL
Marketing Status N/A Discontinued